Events

Nordic Congress in Aalborg, Denmark

17 June – 20 June 2019

The 21st Nordic Congress of General Practice builds on a rich tradition of pioneering research in general medicine.

This event will have a special focus on core values, current challenges and changing practice. The congress brings together clinicians, researchers and administrators, young and experienced, with a shared interest in primary care. The venue in Aalborg holds unique opportunities for exchanging ideas, discussing research and promoting general practice perspectives. The Cimbrian bull, the trademark of Aalborg, stands for strength and stamina; these characteristics provide a solid foundation in a time of shifting sands and changing landscapes.

Read more about the event

About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor system calculates a patient-specific CAD-score non-invasively in less than10 minutes and can help rule out more than one third of patients with at least 96% certainty of not being sick (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, certifiedadviser@redeye.se) is Certified Advisor of Acarix.

For more information, please visit www.acarix.com.